ARCHIVES

DCPC Advisors Upset At NCAB Over Why Decision, But Move On

This article is from The Cancer Letter archive.

Vol. 17 No. 06 | February 8, 1991

Download PDF Visit The Full Archive

Related Articles

Translation Of “New Biology” Into Clinical Use Identified By DeVita As NCI’s Major Challenge

August 16, 1985

Research Funding In Crisis; Scientists Fear Cancer Program’s Dismantling, AACR Says

January 20, 1995

Immunotherapy Demonstrates Disease Control in Phase II Study

September 28, 2012

Dendreon’s Provenge Approved For Prostate Cancer Treatment

April 30, 2010

Boyd’s Rebuttal to DePinho’s Letter to the AAUP

May 30, 2014

AVEO’s Tivozanib Sunk by Fundamental Flaw: Higher Overall Survival in the Control Arm

May 8, 2013